Correlation Between Cellectar Biosciences and Relief Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cellectar Biosciences and Relief Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cellectar Biosciences and Relief Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cellectar Biosciences and Relief Therapeutics Holding, you can compare the effects of market volatilities on Cellectar Biosciences and Relief Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cellectar Biosciences with a short position of Relief Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cellectar Biosciences and Relief Therapeutics.

Diversification Opportunities for Cellectar Biosciences and Relief Therapeutics

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Cellectar and Relief is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Cellectar Biosciences and Relief Therapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relief Therapeutics and Cellectar Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cellectar Biosciences are associated (or correlated) with Relief Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relief Therapeutics has no effect on the direction of Cellectar Biosciences i.e., Cellectar Biosciences and Relief Therapeutics go up and down completely randomly.

Pair Corralation between Cellectar Biosciences and Relief Therapeutics

If you would invest  313.00  in Relief Therapeutics Holding on September 13, 2024 and sell it today you would earn a total of  0.00  from holding Relief Therapeutics Holding or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy0.8%
ValuesDaily Returns

Cellectar Biosciences  vs.  Relief Therapeutics Holding

 Performance 
       Timeline  
Cellectar Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cellectar Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Relief Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Relief Therapeutics Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Relief Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Cellectar Biosciences and Relief Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cellectar Biosciences and Relief Therapeutics

The main advantage of trading using opposite Cellectar Biosciences and Relief Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cellectar Biosciences position performs unexpectedly, Relief Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relief Therapeutics will offset losses from the drop in Relief Therapeutics' long position.
The idea behind Cellectar Biosciences and Relief Therapeutics Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges